Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study

References

• Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2020;75(1):1–10. doi: 10.1053/j.ajkd.2019.04.031.
   PubMed Web of Science ®Google Scholar
• Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71. doi:10.1038/s41572-020-0204-y.
   PubMed Web of Science ®Google Scholar
• Binda V, Moroni G, Messa P. ANCA-associated vasculitis with renal involvement. J Nephrol. 2018;31(2):197–208. doi:10.1007/s40620-017-0412-z.
   PubMed Web of Science ®Google Scholar
• Monti S, Craven A, Klersy C, et al. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. Rheumatology. 2021;60(2):617–628. doi:10.1093/rheumatology/keaa215.
   PubMed Web of Science ®Google Scholar
• Mustapha N, Barra L, Carette S, et al. Efficacy of leflunomide in the treatment of vasculitis. Clin Exp Rheumatol. 2021;39(2):114–118. doi:10.55563/clinexprheumatol/ve38dj.
   PubMed Web of Science ®Google Scholar
• Berti A, Alsawas M, Jawaid T, et al. Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2021;37(11):2190–2200.
   Web of Science ®Google Scholar
• Brilland B, Boud’hors C, Copin MC, et al. Assessment of renal risk score and histopathological classification for prediction of end-stage kidney disease and factors associated with change in eGFR after ANCA-glomerulonephritis diagnosis. Front Immunol. 2022;13:834878. doi:10.3389/fimmu.2022.834878.
   PubMed Web of Science ®Google Scholar
• Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–1594. doi: 10.1136/annrheumdis-2016-209133.
   PubMed Web of Science ®Google Scholar
• Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180–2188. doi:10.1681/ASN.2007010090.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Harada M, Hara Y, et al. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis. Arthritis Res Ther. 2021;23(1):28. doi:10.1186/s13075-021-02415-z.
   PubMed Web of Science ®Google Scholar
• Walsh M, Merkel PA, Peh CA, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382(7):622–631. doi:10.1056/NEJMoa1803537.
   PubMed Web of Science ®Google Scholar
• Fuchs K, Rummler S, Ries W, et al. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications. Ther Apher Dial. 2022;26(1):229–241. doi:10.1111/1744-9987.13663.
   PubMed Web of Science ®Google Scholar
• Zöllner S, Pablik E, Druml W, et al. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two. Blood Purif. 2014;38(2):160–166. doi:10.1159/000367682.
   PubMed Web of Science ®Google Scholar
• Schossee N, Veit G, Gittel J, et al. Profile of the single-use, multiple-pass protein A adsorber column in immunoadsorption. Vox Sang. 2022;117(3):393–398. doi:10.1111/vox.13205.
   PubMed Web of Science ®Google Scholar
• Oji S, Nomura K. Immunoadsorption in neurological disorders. Transfus Apher Sci. 2017;56(5):671–676. doi:10.1016/j.transci.2017.08.013.
   PubMed Web of Science ®Google Scholar
• Yang M, Liao C, Zhu Q, et al. Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population. Clin Rheumatol. 2020;39(12):3581–3592. doi:10.1007/s10067-020-05156-7.
   PubMed Web of Science ®Google Scholar
• Schwenger V, Morath C. Immunoadsorption in nephrology and kidney transplantation. Nephrol Dial Transplant. 2010;25(8):2407–2413. doi:10.1093/ndt/gfq264.
   PubMed Web of Science ®Google Scholar
• Palmer A, Cairns T, Dische F, et al. Treatment of rapidly progressive glomerulonephritis by extracorporeal ­immunoadsorption, prednisolone and cyclophosphamide. Nephrol Dial Transplant. 1991;6(8):536–542. doi:10.1093/ndt/6.8.536.
   PubMed Web of Science ®Google Scholar
• Jin S, Wang D, Luo J, et al. Diffuse alveolar hemorrhage in a patient with anti-neutrophil cytoplasm antibody-associated vasculitis successfully treated with immunoadsorption combined with methylprednisolone. Med Clin. 2022;158(3):133–136. doi:10.1016/j.medcli.2021.08.004.
   PubMed Web of Science ®Google Scholar
• Chu X, Hong Y, Wang Y, et al. Immunoadsorption improves remission rates of patients with antineutrophil cytoplasmic antibody-associated vasculitis and severe kidney involvement. Am J Nephrol. 2021;52(12):899–908. doi:10.1159/000519608.
   PubMed Web of Science ®Google Scholar
• Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171–354. doi:10.1002/jca.21705.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827–1832. doi:10.1136/ard.2008.101279.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Flossmann O, Hellmich B, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism Systemic Vasculitis Task Force. Ann Rheum Dis. 2008;67(7):1004–1010. doi:10.1136/ard.2007.071936.
   PubMed Web of Science ®Google Scholar
• Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488–494. doi:10.1136/ard.2010.137778.
   PubMed Web of Science ®Google Scholar
• Lai QY, Ma TT, Li ZY, et al. Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients. J Rheumatol. 2014;41(9):1849–1855. doi:10.3899/jrheum.131426.
   PubMed Web of Science ®Google Scholar
• Toyoda T, Yates M, Watts RA. Is there still a role of plasma exchange in the current management of ANCA-associated vasculitides? Curr Rheumatol Rep. 2022;24(4):111–117. doi:10.1007/s11926-022-01064-8.
   PubMed Web of Science ®Google Scholar
• Zeng L, Walsh M, Guyatt GH, et al. Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline. BMJ. 2022;376:e064597. doi:10.1136/bmj-2021-064597.
   PubMedGoogle Scholar
• Matic G, Bosch T, Ramlow W. Background and indications for protein A-based extracorporeal immunoadsorption. Ther Apher. 2001;5(5):394–403. doi:10.1046/j.1526-0968.2001.00370.x.
   PubMedGoogle Scholar
• Stegmayr BG, Almroth G, Berlin G, et al. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish Multi-Center Study. Int J Artif Organs. 1999;22(2):81–87. doi:10.1177/039139889902200205.
   PubMed Web of Science ®Google Scholar
• Porges AJ, Redecha PB, Kimberly WT, et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol. 1994;153(3):1271–1280. doi:10.4049/jimmunol.153.3.1271.
   PubMed Web of Science ®Google Scholar
• Sciascia S, Ponticelli C, Roccatello D. Pathogenesis-based new perspectives of management of ANCA-associated vasculitis. Autoimmun Rev. 2022;21(3):103030. doi:10.1016/j.autrev.2021.103030.
   PubMed Web of Science ®Google Scholar
• Mirouse A, Parrot A, Audigier V, et al. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Crit Care. 2020;24(1):231. doi:10.1186/s13054-020-02936-0.
   PubMed Web of Science ®Google Scholar